Furthermore, elevated ERK1/2 phosphorylation has been found in 47.3% (543/1149) of CRC patients (Table 2), and inhibition of ERK1/2 suppressed cell growth and induced apoptosis in the CRC cell line [43]. Here, MAPK3 is linked to colorectal carcinoma.